Overview
Legal representative and major shareholder of Shanghai Luanxin Medical Technology Co., Ltd., holding approximately 47%. Leads development of the MedWorld physical AI healthcare platform, using computational physics for full-scale heart modeling.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
上海孪心医疗科技有限公司法定代表人、大股东（持股约47%），主导物理AI医疗平台MedWorld研发，通过计算物理对心脏进行全尺度建模。